|
|
 |
|
Viewing report
|
|
|
|
Patient Self-Monitoring: Devices, Markets, Players and Prospects
Greystone Associates, May 2011
The ability of patients to monitor their own serum levels is deemed to be a critical tool in reducing the pathological effects of poorly controlled disease factors. For conditions other than diabetes, the vast majority of monitoring has until recently been performed in physician offices or similar healthcare settings. The convergence of new measurement technologies, patient demographics and managed care cost initiatives is driving patient monitoring for a number of conditions from caregiver facilities and into homes. In the process, patient self-monitoring for cholesterol, INR and hypertension have the potential to transition from a cottage industry into a significant market. The key enabler of this significant shift will be technological advances that will provide accurate readings in a format that consumers can understand, clearly indicating when a follow-up visit to a caregiver is needed. Systems that allow patients to share readings with physicians electronically have already been introduced. Ultimately, the success of this self-test market will rely on monitors that can provide accurate values for the various analytes that are associated with health risk, presenting them to the patient in the proper context..
Highlights
- Analyzes and evaluates self-test monitoring technologies and products, and assesses the market potential, commercialization risks and opportunities
- Examines next-generatione monitor technologies, design issues and evolving market factors
- Provides forecasts and market data for self-monitoring products to 2015
- Assesses the impact and influence of self-monitoring enhancements on the healthcare management market
- Profiles self-monitoring market participants, their technology, product development activity, and business strategies
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
